{
    "Trade/Device Name(s)": [
        "NObreath\u00ae"
    ],
    "Submitter Information": "Bedfont Scientific Ltd",
    "510(k) Number": "K203695",
    "Predicate Device Reference 510(k) Number(s)": [
        "K170983"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MXA"
    ],
    "Summary Letter Date": "September 13, 2021",
    "Summary Letter Received Date": "September 14, 2021",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.3080"
    ],
    "Regulation Name(s)": [
        "Breath Nitric Oxide Test System"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "toxicology"
    ],
    "Analyte(s)": [
        "Fractional Exhaled Nitric Oxide (FeNO)",
        "Nitric Oxide"
    ],
    "Specimen Type(s)": [
        "Expired breath",
        "Human breath"
    ],
    "Specimen Container(s)": [
        "Disposable patient mouthpiece with filter"
    ],
    "Instrument(s)/Platform(s)": [
        "NObreath\u00ae main unit",
        "FeNOchart\u2122 software"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical sensor technology",
        "Quantitative measurement"
    ],
    "Methodologies": [
        "Electrochemical detection"
    ],
    "Submission Type(s)": [
        "System",
        "Analyzer",
        "Software",
        "Component",
        "Accessory"
    ],
    "Document Summary": "FDA 510(k) summary for Bedfont NObreath portable analyzer for quantitative measurement of fractional exhaled nitric oxide in breath using electrochemical sensor technology",
    "Indications for Use Summary": "Measurement of fractional exhaled nitric oxide (FeNO) in human breath as an adjunct to established clinical and laboratory assessments for evaluating asthma patients' response to anti-inflammatory therapy; intended for children 7\u201317 years and adults 18 years and older, not for use with infants or in critical/emergency/anesthesiology care",
    "fda_folder": "Toxicology"
}